|
|
|
The RESPImmun Faculty
|
|
ORCID-ID:
|
0000-0002-9056-3063
|
Research areas:
|
|
Molecular pathology, cancer metabolism, cancer micro-environment, lipid metabolism
|
Career history:
|
2008–present
|
Chairman of the Institute of Pathology, Medical University of Graz
|
2005–present
|
Full Professor for Pathology, Department of Pathology, Medical University of Graz
|
2000–2005
|
Associate Professor for Pathology, Department of Pathology, Faculty of Medicine, University of Graz
|
1997
|
Board certification for Pathology and Genetic
|
1995
|
Board certification for Laboratory Medicine
|
1992–2005
|
Associate Professor for Molecular Pathology, Department of Pathology, University of Graz
|
1990–1992
|
Assistant Professor at the Department of Pathology, University of Graz
|
01/1989–09/1990
|
Otto Loewi fellowship (FWF), Department of Medical Biochemistry, University of Graz
|
11/1986–11/1988
|
Erwin-Schrödinger fellowship (FWF), Kennedy Institute for Handicapped Children, Johns Hopkins School of Medicine, Baltimore, MD, USA
|
01/1985–03/1986
|
Department of Pediatrics, Laboratory of Clinical Chemistry and Metabolism, University of Graz
|
1984
|
MD at the University of Graz, Austria
|
1977–1984
|
University education in Medicine at the University of Graz, Austria
|
Career-related activities (5 most important):
|
2017–2019
|
President, Austrian Society of Pathology
|
2009–present
|
Speaker of the FWF-funded “Doctoral College Metabolic and Cardiovascular Disease – DK-MCD”
|
2007–2014
|
Board member of the Austrian Science Fund FWF
|
2006–present
|
European Society for Pathology, European Group for Molecular Pathology, board member;
Secretary 2012–2019, Chair 2019–present
|
Invited referee for > 30 scientific journals and > 10 funding organizations
|
Major honours and awards (5 most important):
|
2000
|
Dissertation award of the Styrian government (P. Staber)
|
1996
|
Research award of the Styrian physicians’ association
|
1992, 1996
|
Research award of the Hoechst Foundation
|
1995
|
Research award of the Styrian government
|
International collaboration partners (5 most important):
|
|
Richard Lehner, University of Alberta, Edmonton, Canada
Peter Espenshade, John Hopkins University, MD, USA
Kivanc Birsoy, Rockefeller University, NY, USA
Tyler Jacks, Koch Institute for Integrative Cancer Research at MIT, MA, USA
Caroline A. Owen, Brigham and Women's Hospital, MA, USA
|
|